Preventing Cognitive Decline with Metformin
Preventing Cognitive Decline with Metformin
Active, not recruiting · NCT04511416 · Registry updated 2024-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Preventing Cognitive Decline with Metformin | Cognition Disorders, Cognitive Decline, Cognitive Dysfunction, Inflammation, Insulin Resistance, Nerve Degeneration, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, nervous system disorder, psychiatric disorder, vascular disorder | Active, not recruiting | Phase 3 | 2024-10-02 | NCT04511416 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Garvan Institute of Medical Research | 2 |
| National Health and Medical Research Council, Australia | 27 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Garvan Institute of Medical Research | Sydney | Australia | 1 |